We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




High-Resolution Analysis of Leishmanial Ribosome Provides Clues for Drug Design

By LabMedica International staff writers
Posted on 08 Sep 2016
Print article
Image: Surface model of Leishmania’s ribosomal large subunit (rLSU) based on the first high-resolution structure, obtained by 2.8-A° cryo-EM. Circled are the locations of three focal points of rLSU rRNA segmentation in regards to the ribosome exit tunnel. 26S rRNA segment-terminals in the leishmanial ribosome were found to converge to these three separate focal points, all located on the solvent-exposed side of the rLSU. The 5.8S rRNA chain is represented as yellow surface and all other chains are represented as cartoon tubes. The study revealed the fragmented nature of leishmanial rRNA and irregular distribution of rRNA modifications, with implications for drug development against Leishmania and related parasites (Photo courtesy of Cell Reports).
Image: Surface model of Leishmania’s ribosomal large subunit (rLSU) based on the first high-resolution structure, obtained by 2.8-A° cryo-EM. Circled are the locations of three focal points of rLSU rRNA segmentation in regards to the ribosome exit tunnel. 26S rRNA segment-terminals in the leishmanial ribosome were found to converge to these three separate focal points, all located on the solvent-exposed side of the rLSU. The 5.8S rRNA chain is represented as yellow surface and all other chains are represented as cartoon tubes. The study revealed the fragmented nature of leishmanial rRNA and irregular distribution of rRNA modifications, with implications for drug development against Leishmania and related parasites (Photo courtesy of Cell Reports).
Derived from a 2.8-Å cryo-EM map, researchers have achieved an atomic resolution structure of the Leishmania donovani large ribosomal subunit (rLSU). Comparison with other eukaryotes and with bacteria provides an important framework for better understanding ribosome biogenesis and a solid structural basis for developing highly selective therapeutics against Leishmania and closely related parasites.

Leishmania is a single-cell eukaryotic parasite of the Trypanosomatidae family of microbes, whose members cause various debilitating and often fatal diseases. A team of researchers from the Weizmann Institute of Science (Rehovot, Israel), University of Michigan Life Sciences Institute (Ann Arbor, MI, USA), and Hebrew University-Hadassah Medical School (Jerusalem, Israel), have now obtained the first high-resolution snapshots of the parasites’ ribosome, providing a detailed structural map of the rLSU.

The unique features that make the Trypanosomatid ribosome distinct from other eukaryotes are what make it such an attractive drug target as “you need to be able to attack the pathogen without harming the host’s cells,” said study co-leader Prof. Georgios Skiniotis, PhD, U. Michigan. Study co-leader Prof. and 2009 Nobel Laureate Ada Yonath, PhD, Weizmann Institute, added: Previous studies were able to obtain resolutions of 5.6 angstroms and 12 angstroms. The new study obtained a resolution of 2.8 angstroms — which revealed a nearly complete atomic structure and new functional details.

Among other findings, the work enabled direct observation of eukaryotic rRNA modifications (e.g. 2’-O methylations) known to play roles in ribosome assembly and function. These observations showed that leishmanial rRNA is fragmented and hyper-modified at unique positions and that fragmented rRNA termini converge into three focal points involving 5.8S.

The study, by Shalev-Benami M, Zhang Y, et al, was published in the July 12, 2016, issue of the journal Cell Reports.

Related Links:
Weizmann Institute of Science
University of Michigan Life Sciences Institute
Hebrew University-Hadassah Medical School
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Cancer Mutation Profiling Liquid Kit
OncoScreen Plus

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.